Storys zum Thema Finanzen

Folgen
Keine Story zum Thema Finanzen mehr verpassen.
Filtern
  • 24.07.2025 – 17:55

    Healthcare Holding Schweiz AG

    Mikrona Group Acquires FTC Dental

    Baar, Switzerland (ots/PRNewswire) - Mikrona Group AG, a leading Swiss provider of solutions for orthodontics and digital dentistry, has acquired FTC Frey Trading & Consulting Sàrl and its affiliated training platform, MYDENTALEXPERT Sàrl. Mikrona Group is part of Healthcare Holding Schweiz AG, which is managed by Winterberg Advisory and KKA Partners. Healthcare Holding Schweiz AG, through its subsidiary Mikrona Group AG, has completed the acquisition of FTC Frey Trading & ...

  • 23.07.2025 – 16:17

    Croma Pharma

    Croma-Pharma GmbH Announces Strategic Milestone as Novaestiq Corp. Joins Waldencast

    Leobendorf, Austria (ots/PRNewswire) - Saypha® injectables to launch in the U.S. under the Obagi Medical brand, expanding global reach of Croma's science-driven aesthetic solutions Croma-Pharma GmbH, a global leader in minimally invasive aesthetic medicine, today announced the acquisition of Novaestiq Corp. by Waldencast plc (Nasdaq: WALD). Novaestiq, a joint venture ...

  • 22.07.2025 – 14:37

    INFOSYS

    Infosys Collaborates with AGCO to Deliver IT and HR Operations Transformation

    Bengaluru, India (ots/PRNewswire) - Building on a longstanding relationship to enhance AGCO's operational framework for growth by leveraging Infosys Cobalt and Infosys Topaz Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced the extension of its strategic collaboration with AGCO Corporation ...

  • 18.07.2025 – 09:01

    Euroclear Group

    Euroclear reports robust H1 2025 results

    Brussels (ots/PRNewswire) - Results for the first half year ended 30 June 2025 Financial highlights Solid business performance and improved operating margin despite challenging geopolitical and macroeconomic environment - Underlying1 business income for H1 2025 reached €932 million, an 8% increase compared to H1 2024. Higher safekeeping revenues, supported by an increase in group depot and in settlement and ...

  • 19.06.2025 – 08:15

    Aduna

    JT Global to join Aduna to advance secure CPaaS solutions with Network APIs

    Plano, Texas (ots/PRNewswire) - Aduna, the global aggregator of network APIs, today announced that JT Global, a leading international Communications as a Service (CPaaS) provider, will join its partner ecosystem to integrate a new set of high-trust network APIs into its communications platform. The partnership will enable JT Global to deliver enhanced authentication, ...

  • 18.06.2025 – 10:15

    Aduna

    Tech Mahindra and Wipro join Aduna to accelerate global adoption of network APIs

    Plano, Texas (ots/PRNewswire) - Aduna, the global aggregator of network APIs, today announced that leading global system integrators, Wipro and Tech Mahindra have joined its partner ecosystem. This strategic collaboration highlights the critical role GSIs play in scaling enterprise adoption and enabling mobile operator participation in the emerging network API economy. ...

  • 18.06.2025 – 08:15

    Aduna

    Syniverse to team up with Aduna to expand access to network APIs

    Plano, Texas (ots/PRNewswire) - Collaboration will combine Syniverse's global enterprise messaging reach with Aduna's unified telecom API platform Aduna, the industry's first global aggregator of network APIs, today announced a strategic partnership with Syniverse, the world's most connected company®. The collaboration will enable Syniverse to integrate with Aduna's unified API platform, which aggregates network APIs ...

  • 17.06.2025 – 13:31

    Isomorphic Labs

    Isomorphic Labs appoints Dr. Ben Wolf as Chief Medical Officer and establishes US Presence

    London and Boston (ots/PRNewswire) - Precision oncology leader joins world-class team as company enters next phase of translating AI-driven drug discovery into life-changing medicines. Isomorphic Labs, the AI-first drug discovery company, has announced the appointment of Ben B. Wolf, M.D., Ph.D., as Chief Medical Officer. Dr. Wolf will be based in the company's newly ...

  • 17.06.2025 – 10:02

    Aduna

    Aduna partners with SoftBank Corp. to expand network API access in Japan

    Plano, Texas (ots/PRNewswire) - Aduna, the global aggregator of network APIs, today announced that it has entered into a strategic commercial partnership with SoftBank Corp. ("SoftBank") as part of a Memorandum of Understanding (MoU). The collaboration will focus on expanding developer access to standardized telecom APIs and supporting industry-wide initiatives such as ...

  • 17.06.2025 – 09:02

    MedHub; Terumo

    MedHub-AI and Terumo partner to market AI-based FFR in Japan

    Tel Aviv, Israel (ots/PRNewswire) - MedHub-AI, pioneer of AI-based FFR "AutocathFFR" software, today announced a distribution agreement with Terumo Corporation to bring AutocathFFR®, its groundbreaking AI-powered Software as a Medical Device (SaMD), to the Japanese market. This partnership marks a new era in coronary physiology assessment where AI technology delivers superior confidence, reproducibility, and clinical ...

  • 16.06.2025 – 19:54

    United Group

    United Group announces leadership changes following strategic re-focus

    London (ots/PRNewswire) - - Stan Miller appointed CEO to lead United Group as it strategically refocuses its business on EU markets following successful sale of non-EU operations - Together with Stan, Libor Voncina appointed deputy CEO, each bring decades of industry experience and proven track record in the European telecoms and media sectors - Founder Dragan Šolak ...

  • 16.06.2025 – 13:40

    Innovative Molecules GmbH

    Innovative Molecules Completes Enrollment of Phase 1b Clinical Trial of IM-250

    Munich (ots/PRNewswire) - Innovative Molecules GmbH Announces Completion of Phase 1b Enrollment for IM-250 in Genital Herpes Clinical Trial Innovative Molecules GmbH today announced the completion of enrollment in the Phase 1b portion of its ongoing Phase 1b/2a clinical trial evaluating IM-250, a next-generation helicase-primase inhibitor targeting herpes simplex virus ...